Quest Diagnostics

Quest Diagnostics Incorporated
Company typePublic
IndustryHealth care
Founded1967; 57 years ago (1967), in New York City, New York, U.S.
FounderPaul Brown
HeadquartersSecaucus, New Jersey, U.S.
Area served
Key people
Jim Davis (CEO)[1]
Services
RevenueDecrease US$9.25 billion (2023)
Decrease US$1.26 billion (2023)
Decrease US$854 million (2023)
Total assetsIncrease US$14.0 billion (2023)
Total equityIncrease US$6.31 billion (2023)
Number of employees
48,000 (2023)
Websitequestdiagnostics.com
Footnotes / references
[2]

Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil.[3] Quest also maintains collaborative agreements with various hospitals and clinics across the globe.[4]

As of 2020, the company had approximately 48,000 employees, and it generated more than $7.7 billion in revenue in 2019.[5][6] The company offers access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders, COVID-19, and employment and court-ordered drug testing.[7]

  1. ^ "Quest Diagnostics - Governance - Management Team". Quest Diagnostics Investor Relations. Retrieved January 17, 2023.[self-published source]
  2. ^ "Quest Diagnostics: 2023 annual report (Form 10-K)". U.S. Securities and Exchange Commission. February 22, 2024. Retrieved March 28, 2024.
  3. ^ "International Facilities & Operations". Quest Diagnostics. Retrieved October 17, 2018.
  4. ^ "Our Growing International Presence". Quest Diagnostics. Archived from the original on March 3, 2012. Retrieved February 15, 2012.
  5. ^ "Quest Diagnostics Incorporated Form 10-K". U.S. Securities and Exchange Commission. December 31, 2017. Retrieved October 17, 2018.
  6. ^ Herman, Holly (June 25, 2020). "Quest Diagnostics recalling many furloughed employees as routine testing rebounds". Reading Eagle. Retrieved August 12, 2020.
  7. ^ "Annual Reports". Quest Diagnostics. December 31, 2015. Retrieved October 26, 2016.